VERA
Price:
$42.61
Market Cap:
$2.72B
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections and is under Phase 2 clinical trial. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartere...[Read more]
Industry
Biotechnology
IPO Date
2021-05-14
Stock Exchange
NASDAQ
Ticker
VERA
According to Vera Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 16.92. This represents a change of -19.47% compared to the average of 21.01 of the last 4 quarters.
The mean historical Current Ratio of Vera Therapeutics, Inc. over the last ten years is 12.49. The current 16.92 Current Ratio has changed 13.44% with respect to the historical average. Over the past ten years (40 quarters), VERA's Current Ratio was at its highest in in the March 2024 quarter at 28.05. The Current Ratio was at its lowest in in the March 2020 quarter at 0.
Average
12.49
Median
9.22
Minimum
3.36
Maximum
25.67
Discovering the peaks and valleys of Vera Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 570.56%
Maximum Annual Current Ratio = 25.67
Minimum Annual Increase = -54.25%
Minimum Annual Current Ratio = 3.36
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 25.67 | 232.79% |
| 2023 | 7.71 | 57.09% |
| 2022 | 4.91 | -54.25% |
| 2021 | 10.73 | -52.41% |
| 2020 | 22.55 | 570.56% |
The current Current Ratio of Vera Therapeutics, Inc. (VERA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
12.76
5-year avg
14.32
10-year avg
12.49
Vera Therapeutics, Inc.’s Current Ratio is less than Celldex Therapeutics, Inc. (19.67), greater than AbCellera Biologics Inc. (10.10), less than Janux Therapeutics, Inc. (35.86), greater than Viridian Therapeutics, Inc. (11.01), greater than Pharvaris N.V. (8.33), greater than Immunome, Inc. (12.13), greater than Biohaven Ltd. (2.86), greater than uniQure N.V. (7.12), greater than Harmony Biosciences Holdings, Inc. (3.75), greater than Nuvation Bio Inc. (8.48),
| Company | Current Ratio | Market cap |
|---|---|---|
| 19.67 | $1.97B | |
| 10.10 | $1.09B | |
| 35.86 | $986.41M | |
| 11.01 | $2.64B | |
| 8.33 | $1.80B | |
| 12.13 | $1.84B | |
| 2.86 | $1.02B | |
| 7.12 | $1.23B | |
| 3.75 | $2.20B | |
| 8.48 | $2.84B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vera Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vera Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Vera Therapeutics, Inc.'s Current Ratio?
How is the Current Ratio calculated for Vera Therapeutics, Inc. (VERA)?
What is the highest Current Ratio for Vera Therapeutics, Inc. (VERA)?
What is the 3-year average Current Ratio for Vera Therapeutics, Inc. (VERA)?
What is the 5-year average Current Ratio for Vera Therapeutics, Inc. (VERA)?
How does the current Current Ratio for Vera Therapeutics, Inc. (VERA) compare to its historical average?